Biogen Idec Revenues Rise 10%; Celgene Gains 15%
By Catherine Shaffer
Friday, April 26, 2013
Biogen Idec Inc. reported total revenues of $1.4 billion in the first quarter of 2013, a 10 percent increase compared to the first quarter of 2012.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.